Evaluation of Modified Treatment Regimens for Treatment of Heavy Menstrual Bleeding Using the HerOption® System

PHASE4CompletedINTERVENTIONAL
Enrollment

82

Participants

Timeline

Start Date

April 30, 2004

Primary Completion Date

October 31, 2007

Study Completion Date

June 30, 2009

Conditions
Menorrhagia
Interventions
DEVICE

Extended treatment regimen using Her Option Cryotherapy

Extended treatment regimens using the Her Option Endometrial Cryotherapy System to more effectively ablate the endometrial lining, reducing menstrual levels to normal or less.

Trial Locations (7)

17011

Jose Manjon, M.D. (Private practice), Camp Hill

27710

Duke University Medical Center, Durham

28262

Center for Endometrial Ablation, Charlotte

33414

Institute for Women's Health & Body, Wellington

48602

Valley OB/GYN, Saginaw

85013

Kelly Roy, M.D., P.C., Phoenix

01805

Lahey Clinic, Burlington

Sponsors
All Listed Sponsors
lead

CooperSurgical Inc.

INDUSTRY

NCT00094536 - Evaluation of Modified Treatment Regimens for Treatment of Heavy Menstrual Bleeding Using the HerOption® System | Biotech Hunter | Biotech Hunter